Independent Solutions

We deliver impartial advice and practical hands on solutions to the Pharmaceutical, Biotechnology & Medical Devices industries independentsolutions.ie #Pharma #BioTech #MedTech #Pharmaceuticals

Are you a Bioscience Manager looking for an excellent conference to network, view cutting edge facilities, hear about latest developments in the field? Check out the University Bioscience Managers Association conference: ubma.org.uk/future-meeting… see you there!

@BusOfSciConf Good luck with the conference. #Science #Business (rt @catherinemross)

Join the debate at the 10th Business of Science Conference. Our expert panel discussions will explore the latest developments shaping the future of science, innovation and industry. For more info: businessofscience.co.uk

@WhTech @TECHOGNITIONUK @Preproom @Philip_HarrisUK @SLSSelectEd @unisontheunion @BrecklandSci :-)

My work bag the teachers know who I am 😊 #TECHOGNITION @TECHOGNITIONUK @Preproom @Philip_HarrisUK @SLSSelectEd @unisontheunion @BrecklandSci

@InnovationMids Good luck in April! #Chemistry #ExtracellularVesicles

Programme now live on our website - don’t miss the chance to sign up to this fascinating and insightful day!

@UofYTechs @BiologyatYork @YorkBioscience Good luck with the candidate search.

#job for a Senior Technical Team Manager; Imaging & Cytometry Deputy & TF Executive in @BiologyatYork @YorkBioscience Apply by 4/4/2026 jobs.york.ac.uk/vacancy/senior…

Check out our ongoing Irish countrywide pharmaceutical opportunities on our website! Talk to us about our Referrals Reward System today independentsolutions.ie/job-opportunit… #Pharma #BioTech #MedTech #Jobfairy

The website for the 77th Irish Universities Chemistry Research Colloquium is now live and can be accessed using this link: ucc.ie/en/chemistry/c…

@ucdchemistry Good luck with the new recruit! (rt @TheRubiniGroup)

We are currently recruiting for an Associate Professor of Medicinal Chemistry & Chemical Biology, closing date 31/03/2026. For more details see timeshighereducation.com/unijobs/listin… or ucd.ie/chem/vacancies/ Retweets appreciated

Our Project managers successfully deploy projects of various types!! Read more about how we can help you here. > independentsolutions.ie/services/proje… #ProjectManagement #Pharma #BioTech #MedTech

An Post Issues Stamps Honouring Irish Women in Medicine ucd.ie/medicine/news/… from @UCDMedicine #Ireland #WomeninSTEM

@PhylFerrell @DavosAlzheimers @adpdnet Good luck with the rest of #ADPD2026!

Come see the #DAC Team at poster 442 at #ADPD2026 and learn more about the #healthsystempreparedness #accuratediagnosis program @DavosAlzheimers @adpdnet

We are pleased to report updated clinical data for aglatimagene besadenovec (CAN-2409) in advanced non-small cell lung cancer (NSCLC) patients with inadequate response to immune checkpoint inhibitors. With an additional 12 months of follow-up, the data continue to strengthen the durability of the survival tail, with 50% of patients in the per-protocol population alive beyond 24 months and median overall survival of 25.4 months, approximately two-fold higher than historical outcomes with standard of care docetaxel in this setting. Equally important, these outcomes are supported by a compelling mechanistic package, including induction of pro-inflammatory pathways and expansion of T-cell receptor diversity, consistent with broad immune activation and “cold-to-hot” tumor conversion. Following our recent financing, we are well positioned to execute and are now advancing toward the imminent initiation of a pivotal phase 3 trial in non-squamous NSCLC. We believe this program has the potential to redefine outcomes for patients who have limited options after checkpoint inhibitor therapy. Thank you to the patients, investigators, and our team for making this progress possible. globenewswire.com/news-release/2…

@ImmaginaBiotech Excellent work Alessia.

To celebrate International Women’s Day, this month’s spotlight is on Alessia, R&D Project Manager. Starting at Immagina after her Master’s, she developed a translatome biomarker platform, earned her PhD in 2024, and now leads key projects in the R&D department. Get to know her!

@CardioPhoenix1 Innovative. #HeartHealth

Most #heart disease is detected too late because advanced cardiac diagnostics are rarely available in primary care. AI cardiac diagnostic devices may help change that. See how Cardio-HART analyses ECG and biosignals.

@DonaldBaril @VESurgery @VascularSurgCS @DeptSurgeryCS @DrAliAzizzadeh Congratulations to all involved.

Two great presentations here @VESurgery by our fellow Dr. Jessica Efird and our research resident Dr. Mo Ayouty. @VascularSurgCS @DeptSurgeryCS @DrAliAzizzadeh

@ClaimMD We hope that it was a success.

Claim.MD is a Community Sponsor of the Behavioral HealthTech Conference in San Diego. We look forward to connecting with you at Behavioral HealthTech! Learn more: claim.md

Throughout 2025, fraud schemes drained millions from healthcare programs. Billing for services never rendered. Enrolling patients who don't meet eligibility criteria. Approving tests without ever evaluating patients. Learn more about FWA Insights: hubs.ly/Q042vjrS0

@ICOPA2026 @WorldFedPara Good luck with the abstract processing! (rt @AS_Para)

Abstract deadline extended to 16 Feb 2026! If you’ve been refining results or waiting on that last analysis, now’s the moment to put your work on the #ICOPA2026 program. Make your research part of the conversation 👉 bit.ly/4rgzVwG #Parasitology @WorldFedPara

@sarah_sloat_ Indeed.

Limiting mRNA research puts us at risk if there’s another pandemic or a bioweapon attack. It also keeps us vulnerable to the medical challenges we’re already encountering. Here's my story on the scientists trying to good work for as long as they can: damemagazine.com/2025/08/28/rkf…